Vasant Narasimhan
Bertrand Bodson, Chief Digital Officer at Novartis, suggested that manufacturing is only the beginning point. “Using data science and digital technologies to reimagine the way we manufacture medicines is not only at the heart of our transformation, but also core to our ambition to bring innovative medicines to patients faster,” Bodson stated. In significantly less than two years considering the fact that assuming the prime executive part, Narasimhan has been taking substantive actions to remake Novartis. This contains offloading non-core assets, producing acquisitions to add additional sophisticated medicines to the company’s portfolio, and collaborating on digital healthcare initiatives. Narasimhan says...